This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokota, S.-I.
Right arrow Articles by Yokochi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokota, S.-I.
Right arrow Articles by Yokochi, T.

 Previous Article  |  Next Article 

Infection and Immunity, January 2000, p. 151-159, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Two Distinct Antigenic Types of the Polysaccharide Chains of Helicobacter pylori Lipopolysaccharides Characterized by Reactivity with Sera from Humans with Natural Infection

Shin-Ichi Yokota,1,dagger Ken-Ichi Amano,1,* Yoshiko Shibata,1 Mizuho Nakajima,1 Miyuki Suzuki,1 Shunji Hayashi,2 Nobuhiro Fujii,3 and Takashi Yokochi4

Central Research Laboratory, Akita University School of Medicine, Akita 010-8543,1 Department of Microbiology, Jichi Medical School, Minamikawachi, Tochigi 329-0498,2 Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo 060-8556,3 and Department of Microbiology, Aichi Medical School, Nagakute, Aichi 480-1195,4 Japan

Received 28 June 1999/Returned for modification 25 August 1999/Accepted 11 October 1999

We have purified lipopolysaccharides (LPS) from 10 Helicobacter pylori clinical isolates which were selected on the basis of chemotype and antigenic variation. Data from immunoblotting of the purified LPS with sera from humans with H. pylori infection and from absorption of the sera with LPS indicated the presence of two distinct epitopes, termed the highly antigenic and the weakly antigenic epitopes, on the polysaccharide chains. Among 68 H. pylori clinical isolates, all smooth strains possessed either epitope; the epitopes were each carried by about 50% of the smooth strains. Thus, H. pylori strains can be classified into three types on the basis of their antigenicity in humans: those with smooth LPS carrying the highly antigenic epitope, those with smooth LPS carrying the weakly antigenic epitope, and those with rough LPS. Sera from humans with H. pylori infection could be grouped into three categories: those containing immunoglobulin G (IgG) antibodies against the highly antigenic epitope, those containing IgG against the weakly antigenic epitope, and those containing both specific IgGs; these groups made up about 50%, less than 10%, and about 40%, respectively, of all infected sera tested. In other words, IgG against the highly antigenic epitope were detected in more than 90% of H. pylori-infected individuals with high titers. IgG against the weakly antigenic epitope were detected in about 50% of the sera tested; however, the antibody titers were low. The two human epitopes existed independently from the mimic structures of Lewis antigens, which are known to be an important epitope of H. pylori LPS. No significant relationship between the reactivities toward purified LPS of human sera and a panel of anti-Lewis antigen antibodies was found. Moreover, the reactivities of the anti-Lewis antigen antibodies, but not human sera, were sensitive to particular alpha -L-fucosidases. The human epitopes appeared to be located on O-polysaccharide chains containing endo-beta -galactosidase-sensitive galactose residues as the backbone. Data from chemical analyses indicated that all LPS commonly contained galactose, glucosamine, glucose, and fucose (except one rough strain) as probable polysaccharide components, together with typical components of inner core and lipid A. We were not able to distinguish between the differences of antigenicity in humans by on the basis of the chemical composition of the LPS.


* Corresponding author. Mailing address: Central Research Laboratory, Akita University School of Medicine, 1-1-1, Hondo, Akita 010-8543, Japan. Phone: 81-18-884-6190. Fax: 81-18-884-6452. E-mail: amanocrl{at}med.akita-u.ac.jp.

dagger Present address: HSP Research Institute, Kyoto Research Park, Shimogyo-ku, Kyoto 600-8813, Japan.


Infection and Immunity, January 2000, p. 151-159, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Eaton, K. A., Logan, S. M., Baker, P. E., Peterson, R. A., Monteiro, M. A., Altman, E. (2004). Helicobacter pylori with a Truncated Lipopolysaccharide O Chain Fails To Induce Gastritis in SCID Mice Injected with Splenocytes from Wild-Type C57BL/6J Mice. Infect. Immun. 72: 3925-3931 [Abstract] [Full Text]  
  • SALGADO, F., GARCIA, A., ONATE, A., GONZALEZ, C., KAWAGUCHI, F. (2002). Increased in-vitro and in-vivo biological activity of lipopolysaccharide extracted from clinical low virulence vacA genotype Helicobacter pylori strains. J Med Microbiol 51: 771-776 [Abstract] [Full Text]  
  • Hynes, S. O., Broutet, N., Eurohepygast Study Group, , Wadstrom, T., Mikelsaar, M., O'Toole, P. W., Telford, J., Engstrand, L., Kamiya, S., Mentis, A. F., Moran, A. P. (2002). Phenotypic Variation of Helicobacter pylori Isolates from Geographically Distinct Regions Detected by Lectin Typing. J. Clin. Microbiol. 40: 227-232 [Abstract] [Full Text]  
  • Heneghan, M. A., McCarthy, C. F., Janulaityte, D., Moran, A. P. (2001). Relationship of Anti-Lewis x and Anti-Lewis y Antibodies in Serum Samples from Gastric Cancer and Chronic Gastritis Patients to Helicobacter pylori-Mediated Autoimmunity. Infect. Immun. 69: 4774-4781 [Abstract] [Full Text]  
  • APPELMELK, B J, VANDENBROUCKE-GRAULS, C M J E (2000). H pylori and Lewis antigens. Gut 47: 10-11 [Full Text]